Breaking News

CDMO ExcellGene and Cytena Form Collaboration

Partnership will reduce timelines by automating workflows for cell line development.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cytena, a provider of high-precision instruments for handling biological cells, has entered a collaboration agreement with ExcellGene SA, a biologics contract development and manufacturing organization (CDMO) that manufactures recombinant proteins. Together, the companies will streamline cell line development workflows for highly-efficient monoclonal antibody (mAb) and complex therapeutic protein manufacturing which enables important improvements to the development workflows of the biopharmaceut...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters